Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Debt / NOTE 2.000% 8/1
-
Number of holders
-
19
-
Total principal
-
231M
-
Principal change
-
-22.8M
-
Total reported value, excl. options
-
$157M
-
Value change
-
-$2B
-
Number of buys
-
7
-
Number of sells
-
-14
-
Price
-
$0.66
Significant Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q3 2016
19 filings reported holding 00767EAB8 - AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q3 2016.
AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 has 19 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $231M of principal
.
Largest 10 bondholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC ($67.6M of principal), UBS OCONNOR LLC ($30.5M of principal), Allianz Asset Management GmbH ($28.7M of principal), BAKER BROS. ADVISORS LP ($26.5M of principal), Stonepine Capital Management, LLC ($24.2M of principal), Tekla Capital Management LLC ($13M of principal), AMERIPRISE FINANCIAL INC ($12.1M of principal), Telemetry Investments, L.L.C. ($7M of principal), CITADEL ADVISORS LLC ($6.5M of principal), and NOMURA HOLDINGS INC ($3.5M of principal).
This table shows the top 19 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.